Wealth Enhancement Advisory Services LLC lowered its holdings in AMETEK, Inc. (NYSE:AME - Free Report) by 56.5% during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 50,139 shares of the technology company's stock after selling 65,055 shares during the quarter. Wealth Enhancement Advisory Services LLC's holdings in AMETEK were worth $9,235,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds have also recently modified their holdings of the company. Bares Capital Management Inc. acquired a new position in shares of AMETEK during the 1st quarter worth about $26,000. Olde Wealth Management LLC purchased a new stake in AMETEK during the 1st quarter valued at approximately $29,000. Annis Gardner Whiting Capital Advisors LLC raised its stake in shares of AMETEK by 57.7% during the 1st quarter. Annis Gardner Whiting Capital Advisors LLC now owns 194 shares of the technology company's stock worth $33,000 after buying an additional 71 shares in the last quarter. Zions Bancorporation National Association UT purchased a new position in shares of AMETEK during the 1st quarter worth approximately $42,000. Finally, Costello Asset Management INC purchased a new position in shares of AMETEK during the 1st quarter worth approximately $43,000. Hedge funds and other institutional investors own 87.43% of the company's stock.
AMETEK Trading Up 0.3%
AMETEK stock opened at $188.48 on Tuesday. The company has a market capitalization of $43.53 billion, a price-to-earnings ratio of 30.35, a PEG ratio of 2.70 and a beta of 1.10. The company's fifty day moving average price is $184.09 and its two-hundred day moving average price is $177.18. AMETEK, Inc. has a one year low of $145.02 and a one year high of $198.33. The company has a debt-to-equity ratio of 0.15, a current ratio of 1.63 and a quick ratio of 1.04.
AMETEK (NYSE:AME - Get Free Report) last released its earnings results on Thursday, July 31st. The technology company reported $1.78 earnings per share for the quarter, beating the consensus estimate of $1.69 by $0.09. The business had revenue of $1.78 billion during the quarter, compared to analysts' expectations of $1.74 billion. AMETEK had a net margin of 20.60% and a return on equity of 16.53%. The firm's revenue was up 2.5% on a year-over-year basis. During the same quarter last year, the company earned $1.66 earnings per share. AMETEK has set its Q3 2025 guidance at 1.720-1.760 EPS. FY 2025 guidance at 7.060-7.200 EPS. On average, analysts forecast that AMETEK, Inc. will post 7.15 earnings per share for the current fiscal year.
AMETEK Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Tuesday, September 30th. Stockholders of record on Monday, September 15th will be paid a $0.31 dividend. The ex-dividend date is Monday, September 15th. This represents a $1.24 dividend on an annualized basis and a dividend yield of 0.7%. AMETEK's payout ratio is 19.97%.
Wall Street Analyst Weigh In
A number of equities research analysts recently weighed in on the company. Melius Research upgraded AMETEK to a "hold" rating in a report on Monday, July 14th. KeyCorp raised their price objective on AMETEK from $195.00 to $205.00 and gave the stock an "overweight" rating in a report on Friday, August 1st. Melius cut AMETEK from a "buy" rating to a "hold" rating and set a $192.00 price objective on the stock. in a report on Monday, July 14th. Mizuho lifted their target price on AMETEK from $212.00 to $225.00 and gave the company an "outperform" rating in a report on Friday, August 1st. Finally, TD Cowen upgraded AMETEK from a "sell" rating to a "hold" rating and lifted their target price for the company from $158.00 to $180.00 in a report on Tuesday, September 2nd. Seven research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company's stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average price target of $205.00.
Check Out Our Latest Stock Analysis on AMETEK
AMETEK Profile
(
Free Report)
AMETEK, Inc manufactures and sells electronic instruments and electromechanical devices in the North America, Europe, Asia, and South America, and internationally. The company's EIG segment offers advanced instruments for the process, aerospace, power, and industrial markets; process and analytical instruments for the oil and gas, petrochemical, pharmaceutical, semiconductor, automation, and food and beverage industries; instruments to the laboratory equipment, ultra-precision manufacturing, medical, and test and measurement markets; power quality monitoring and c devices, uninterruptible power supplies, programmable power and electromagnetic compatibility test equipment, and sensors for gas turbines and dashboard instruments; heavy trucks, instrumentation, and controls for the food and beverage industries; and aircraft and engine sensors, power supplies, embedded computing, monitoring, fuel and fluid measurement, and data acquisition systems for aerospace and defense industry.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider AMETEK, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and AMETEK wasn't on the list.
While AMETEK currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.